Clinical trial
Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies…
NCT00369538 · University Hospital, Strasbourg, France, Other · Suspended
Key facts
| NCT number | NCT00369538 |
|---|---|
| Title | Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria |
| Official title | Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria |
| Lead sponsor | University Hospital, Strasbourg, France, Other |
| Status | Suspended |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Proteinuria, Hypertension, End Stage Renal Disease |
| Intervention type | Drug |
| Interventions | losartan, hydrochlorothiazide |
| Enrollment | 20 |
| Start date | Aug 1, 2006 |
| First posted | Aug 29, 2006 |
| Last update posted | Feb 18, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: